checkAd

     154  0 Kommentare GenMark Diagnostics Chosen as Primary Provider of Rapid Diagnostic Testing for Vidant Health - Seite 2

    Harlow noted that the ability to get diagnostic test results in near real-time helps providers across all Vidant’s facilities quickly determine if they have the capacity to treat ill patients based on their diagnoses, or need to transport them to their larger facilities for care. It also will help them determine which patients can safely proceed with surgery.

    “Vidant Health understands that the ability to rapidly test their patients for a variety of respiratory pathogens with syndromic testing is vital to providing high-quality care to their patients and preventing their facilities from becoming overwhelmed,” said Scott Mendel, President and CEO of GenMark. “With the onset of the pandemic, this type of testing – for a wide range of pathogens with a single test – has become critical for population and resource management. It’s the future of diagnostic testing.”

    Vidant Medical Center in Greenville is the 21st largest hospital in the country, and the system serves 1.4 million people across 29 counties.

    “We’re thrilled to partner with GenMark and have been impressed with their service. We’ve been dealing with a lot of uncertainty across the healthcare industry as a result of the pandemic, but working with GenMark we’ve been able to get concrete answers about what they could deliver and when, with no ambiguity and no overpromising,” said Harlow. “It’s given us great peace of mind to be able to plan ahead and not have to wonder if we’ll be able to get tests when we need them. We already know GenMark will have them for us.”

    About GenMark Diagnostics
    GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor detection technology, GenMark's eSensor XT-8 and ePlex systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections.  For more information, visit www.genmarkdx.com.

    Seite 2 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    GenMark Diagnostics Chosen as Primary Provider of Rapid Diagnostic Testing for Vidant Health - Seite 2 Largest health system in eastern North Carolina turns to ePlex platform for fast results on SARS-CoV-2, respiratory and blood stream infectionsCARLSBAD, Calif., June 16, 2020 (GLOBE NEWSWIRE) - GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading …